- Ngā maimoatanga
- Ngā Whakaaturanga
- Neuroblastoma
- Puku totoka
- Ngā Whakaaturanga
- TIL
- Te Whakaora Pūtau NK
- Te Maistenia Gravis (MG)
- Te Mate Pūkahukahu Lymphoblastic Whakapeka (B-ALL)
- Lupus Erythematosus Pūnaha (SLE)
- Te mate pukupuku lymphoblastic whakapeka (T-ALL)
- Lymphoma Kore-Hodgkin (NHL)
- Myeloma maha (MM)
- Lymphom Pūtau-B Nui e horapa ana
- Leukemia B-lymphocytic
- Myeloma
CAR-T mō te Mate Pūkahukahu Lymphoblastic Pūtau-B (B-ALL)
Tirohanga Whānui
Ko te B-ALL (Acute B-cell Lymphoblastic Leukemia) he momo leukemia kaha, e pā ana ki ngā tamariki me ngā taiohi. Ahakoa ngā whanaketanga o te chemotherapy tuku iho, he maha ngā tūroro e pāngia ana e te hokinga mai o te mate, e te ātete rānei ki te maimoatanga. Ko te rongoā CAR-T (Chimeric Antigen Receptor T-cell) he rongoā ārai mate hou kua whakaatu i te angitu whakamiharo ki te rongoā i te B-ALL kua hoki mai, kua ātete rānei, e tuku ana i te tumanako ki ngā tūroro i mua he iti noa ngā kōwhiringa maimoatanga.
He aha te rongoā CAR-T?
He maimoatanga matatau, he maimoatanga whaiaro te rongoā CAR-T e uru ana ki te whakarerekē i ngā pūtau-T o te tūroro kia mōhio ai, kia whakaeke ai hoki i ngā pūtau matepukupuku. Mō te B-ALL, ka hangaia ngā pūtau CAR-T kia aro atu ki te antigen CD19, he pūmua e kitea nuitia ana i te mata o ngā pūtau matepukupuku pūtau-B. Kia whakahokia ki roto i te tinana o te tūroro, ka rapua e ēnei pūtau-T kua hangaia, ka whakangaromia hoki ngā pūtau matepukupuku, ā, ka roa pea te wā e murua ai te mate.
Ngā Painga Matua o te Whakaora CAR-T mō te B-ALL
- Teitei o te Whai HuatangaKua whakaatuhia e te rongoā CAR-T te angitu nui ki te rongoā i te B-ALL kua hoki mai, kua uaua rānei te rongoā, ā, he nui te tere o te murunga hara i roto i ngā tūroro kāore i aro ki ngā maimoatanga tuku iho.
- Mahi WhaiaroMā te arotahi ki te pūmua CD19, ka aro tika te rongoā CAR-T ki ngā pūtau B-ALL, ka whakangaro hoki, ka whakaiti i te kino ki ngā kiko hauora.
- Maimoatanga WhaiaroNā te mea i ahu mai ngā pūtau CAR-T i te pūnaha ārai mate o te tūroro, he tino whaiaro te rongoā, ka whakanui ake i tōna whai huatanga me te whakaiti i te tūponotanga o te whakakorenga.
- Murunga PumauI roto i te nuinga o ngā wā, kua hua ake te murunga roa mā te rongoā CAR-T, e tuku ana i te pūmanawa mō ngā tūroro kia ora mō te wā roa me te iti ake o ngā hokinga mai.
Tukanga Maimoatanga
- Kohinga o ngā pūtau-TKo te taahiraa tuatahi ko te kohikohi i ngā pūtau-T mai i te toto o te tūroro mā te tukanga e kiia nei ko te leukapheresis.
- Te hanga pūtau-TKo ngā pūtau-T kua kohia ka whakarerekētia ira i roto i te taiwhanga hei whakaatu i tētahi kaiwhakawhiwhi antigen chimeric (CAR) e motuhake ana ki te CD19, ka whakarei ake i tō rātou kaha ki te aro ki ngā pūtau B-ALL.
- Te werohanga o ngā pūtau CAR-TI muri i tētahi wā poto o te whakawhānui pūtau, ka tukuna anō ngā pūtau CAR-T kua hangaia ki roto i te tinana o te tūroro mā te werohanga ā-uaua (IV).
- Aroturuki me te WhakaoraWhai muri i te werohanga, ka tirotirohia tata ngā tūroro mō ngā pānga taha pea pērā i te cytokine release syndrome (CRS) me te neurotoxicity. Ko te tikanga, ka taea te whakahaere i ēnei tauhohenga, ā, ka ora te nuinga o ngā tūroro mā te wawaotanga tika.
He aha i whiriwhiri ai koe i te rongoā CAR-T a BIOOCUS mō te B-ALL?
- Hangarau HouKa whakamahia e BIOOCUS ngā hangarau hou hei whakarite i te whakaputanga pūtau CAR-T tino pai me ngā putanga pai mō ngā tūroro.
- Te Rōpū Hauora TohungaKei te whakapau kaha tā mātou tīma tohunga i roto i te hematology me te immunotherapy ki te whakarato i te tiaki whaiaro me te whakanui ake i te angitu o ia maimoatanga.
- Wheako Ao WhānuiKa tukuna e mātou te rongoā CAR-T ki ngā tūroro o te ao katoa, me te hītori o ngā maimoatanga angitu me te murunga mō te wā roa mō ngā tūroro B-ALL.
- Manaaki WhānuiMai i te kōrero tuatahi tae noa ki te aroturukitanga whai muri, ka whakaratohia e BIOOCUS te tiaki whānui, kia whiwhi ai ngā tūroro i te maimoatanga pai rawa atu i ia wāhanga.
Ngā Taunakitanga Hauora me ngā Reiti Angitu
Kua whakaatuhia e ngā whakamātautau haumanu tata nei me ngā raraunga o te ao tūturu he tino pai ngā hua o te rongoā CAR-T mō te B-ALL, inā koa mō ngā tūroro kua hoki anō ki te mate, kua ātete rānei ki ngā maimoatanga tuku iho. Kua whakaatuhia tonutia e te rongoā he nui ngā reiti murunga hara, ā, he maha ngā tūroro i tutuki te murunga hara katoa me te pupuri i te oranga mō te wā roa.
I BIOOCUS, kua angitu tā mātou rongoā i te tini o ngā tūroro me te B-ALL mā te whakamahi i te rongoā CAR-T, ā, he tino pai ngā hua. Mō te māramatanga hohonu ake ki ngā kōrero angitu me ngā hua o te ao tūturu, tirohia ngā rangahau take tūroro e whai ake nei:
- Kōrero mō te Tūroro: Te B-ALL mōrearea nui, te whakawhitinga wheua i te 9 marama—E rua tau i muri mai, he tīmatanga hauora
- Mai i te Korenga Tuatahi o te Tārua ki te Whakaora Katoa: He Haerenga a te Tūroro me te Tārua Matatau a Lu Daopei
- Ngā Mōhiotanga Hua me ngā Akoranga Take mō te Leukemia Lymphoblastic Acute (B-ALL)
E whakaatu ana ēnei kēhi i te kaha whakarerekētanga o te rongoā CAR-T mō ngā tūroro B-ALL, e whakaatu ana i te whai huatanga o te maimoatanga me tōna kaha hoki ki te tuku i tētahi whai wāhitanga tuarua ki te ora ki ngā tūroro.
Raraunga Hauora
Ngā tohu mō te CD19+20CAR-T:Ngā tūroro e pāngia ana e te lymphoma kore-pūtau-B a Hodgkin
| Reiti CR kotahi marama | Te utu PR kotahi marama | Kotahi marama OR reiti | CRS≥3 | CRES≥3 |
| 71.95%(59/82) | 25.6(21/82) | 97.55(80/82) | 12.19%(10/82) | 0 |
Ngā tohu mō te CD19+22CAR-T:Te maimoatanga o ngā tūroro mate pukupuku toto B-lymphocytic whakapeka kua hoki mai te CD19 me te uaua ki te mahi
| Reiti CR kotahi marama | Te utu PR kotahi marama | Kotahi marama OR reiti | CRS≥3 | CRES≥3 |
| 92.1%(35/38) | 7.9%(3/38) | 100%(38/38) | 15.79%(6/38) | 0 |
Ngā tohu mō te BCMACAR-T:Te maimoatanga o te myeloma maha kua hoki mai me te uaua ki te whakatika
| Reiti CR kotahi marama | Te utu PR kotahi marama | Kotahi marama OR reiti | CRS≥3 | CRES≥3 |
| 72.41%(21/29) | 27.59%(8/29) | 100%(29/29) | 6.9%(2/29) | 0 |
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.



